Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gain Therapeutics (GANX)
NASDAQ:GANX
Holding GANX?
Track your performance easily
Gain Therapeutics (GANX) Ownership Overview
4.90% Insiders
1.32% Mutual Funds
3.61% Other Institutional Investors
0.66% ETFs
89.51% Public Companies and
Individual Investors
The ownership structure of Gain Therapeutics (GANX) stock is a mix of institutional, retail, and individual investors. Approximately 5.58% of the company’s stock is owned by Institutional Investors, 4.90% is owned by Insiders, and 89.51% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 12, 2024 | Khalid Islam Ec,director | xxxxxxxxxxxxx | $49500 |
| Aug 12, 2024 | Gene Mack Cfo And Interim Ceo | xxxxxxxxxxxxx | $14544 |
| Jul 01, 2024 | Eric Richman Director | xxxxxxxxxxxxx | $20670 |
| Apr 01, 2024 | Jeffrey Scott Riley Director | xxxxxxxxxxxxx | $115500 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $595573 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 930,784 | Insider | 3.51% | 1,507,870 | |
| 588,410 | Institution | 2.22% | 953,224 | |
| 334,592 | Institution | 1.26% | 542,039 | |
| 304,458 | Insider | 1.15% | 493,222 | |
| 166,354 | Institution | 0.63% | 269,493 | |
| 135,702 | Institution | 0.51% | 219,837 | |
| 135,702 | Institution | 0.51% | 219,837 | |
| 40,000 | Institution | 0.15% | 64,800 | |
| 38,783 | Institution | 0.15% | 62,828 | |
| 30,000 | Insider | 0.11% | 48,600 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 166,354 | Institution | 0.63% | 269,493 | |
| 135,702 | Institution | 0.51% | 219,837 | |
| 40,000 | Institution | 0.15% | 64,800 | |
| 7,043 | Institution | 0.03% | 11,410 | |
| 1,011 | Institution | <0.01% | 1,638 | |
| 238 | Institution | <0.01% | 386 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 135,702 | Institution | 0.51% | 339,255 | |
| 38,783 | Institution | 0.15% | 62,828 |
FAQ
Who Owns Gain Therapeutics (GANX)?
According to the latest TipRanks data, approximately 3.61% of the company's stock is held by institutional investors, 4.90% is held by insiders, and 89.51% is held by retail investors.
What percentage of Gain Therapeutics (GANX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.61% of Gain Therapeutics (GANX) stock is held by institutional investors.
What percentage of Gain Therapeutics (GANX) stock is held by retail investors?
According to the latest TipRanks data, approximately 89.51% of Gain Therapeutics (GANX) stock is held by retail investors.
Who owns the most shares of Gain Therapeutics (GANX)?
Khalid Islam owns the most shares of Gain Therapeutics (GANX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.